Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
What is registered but not yet reported The first registered human efficacy trial for BPC-157 is NCT07437547, a Phase 2 randomized, double-blind, placebo-controlled trial in acute MRI-confirmed grade II hamstring strain, with roughly 120 participants planned and co-primary endpoints of time to unrestricted return to sport and Day-14 MRI injury volume
Warnings and precautions In the literature neuropathies are described under long term intake (6-12 months) of more than 50 mg mean daily dose of vitamin B6
As an investigational peptide, any legitimate clinical use involves a licensed provider, a prescription, and compounding through a licensed pharmacy
How many flavors you got
Like, its weird
The psychological impact of visible cosmetic improvements should not be underestimated in maintaining motivation throughout lengthy protocols
